Phase I trial of short-course chemoradiotherapy followed by chemotherapy as total neoadjuvant therapy for patients with potentially resectable gastric cancer. This is an ASCO Meeting Abstract from the ...
Preliminary results of surufatinib (Suru) plus standard chemotherapy (ChT) as second line (2L) treatment of advanced gastric cancer (aGC): A single-arm, phase 2 clinical trial. Phase 1b/II study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results